Rating Change
Piper Sandler analysts reiterated a Overweight rating on Glaukos Corporation (NYSE:GKOS) on July 01, 2026.
Rating Change Piper Sandler analysts reiterated a Overweight rating on Glaukos Corporation (NYSE:GKOS) on July 01, 2026. Market Context Glaukos Corporation operates in the…

Piper Sandler analysts reiterated a Overweight rating on Glaukos Corporation (NYSE:GKOS) on July 01, 2026.
Glaukos Corporation operates in the Healthcare sector. The stock currently trades at $137.57 with a market capitalization of $6.3B.
Analyst coverage from Piper Sandler provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Glaukos Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 01, 2026 | Piper Sandler | Overweight | N/A |
| Jun 17, 2026 | Needham | Buy | N/A |
| Jun 11, 2026 | Citigroup | Buy | N/A |
| Jun 10, 2026 | BTIG | Buy | N/A |
| May 21, 2026 | BTIG | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View GKOS Stock Page
A Overweight rating from Piper Sandler reflects the analyst's outlook on Glaukos Corporation (NYSE:GKOS). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the GKOS forecast page.
Current market data
NYSE · GKOS
$184.89
Unchanged: $0.00 · 0.00%
Live quote updated
Keep reading